Overview

Meditoxin® Treatment in Patients With Cervical Dystonia

Status:
Completed
Trial end date:
2018-11-05
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of Meditoxin in subjects with cervical dystonia compared with placebo (normal saline)
Phase:
Phase 3
Details
Lead Sponsor:
Medy-Tox
Treatments:
Botulinum Toxins, Type A